The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer.
about
Body composition changes in females treated for breast cancer: a review of the evidenceThe muscle mass, omega-3, diet, exercise and lifestyle (MODEL) study - a randomised controlled trial for women who have completed breast cancer treatment.Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial.Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with body composition changes in women on aromatase inhibitors for ER (+) breast cancer.The role of estrogens in control of energy balance and glucose homeostasis.Impact + resistance training improves bone health and body composition in prematurely menopausal breast cancer survivors: a randomized controlled trial.Muscle function and omega-3 fatty acids in the prediction of lean body mass after breast cancer treatment.Postmenopausal breast cancer, androgens, and aromatase inhibitors.A comprehensive review of sexual health concerns after cancer treatment and the biopsychosocial treatment options available to female patients.Detection of formestane abuse by mass spectrometric techniques.Adjuvant endocrine therapy in women with oestrogen-receptor-positive breast cancer: how should the skeletal and vascular side effects be assessed and managed?The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors.
P2860
Q27004662-E265F3BB-E2F0-485E-866A-9D41A47C6C8CQ33552584-2F0990E4-CC95-43F9-A5A8-AF7F7992BD58Q35072496-D5EEA5DC-1D9D-44FC-B03F-21D5E20047E8Q35842073-A9D933A7-B409-4D68-A559-CADBB5C22B12Q36864744-1B6A5D7C-CBE1-4573-9F52-9962F69F375BQ37376419-9E4F26B0-406E-4182-A924-C643465B60ECQ37439648-1160B281-C952-44F4-8CB7-C70A6B5353B0Q38097730-3AC42F3A-EA6F-4DB2-8AB1-D59B72C6AA7FQ47670995-0ABC52D1-737A-4991-965A-E1AFFD2070A2Q51024470-85DCE2C7-13C9-42E2-B3F6-97C4A59A9101Q51590037-3FC0B8D3-AE19-4112-A486-7A667AD413F4Q53608272-B4B1DA82-9C75-4C78-8123-ED96D704FB8C
P2860
The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The impact of an aromatase inh ...... s in women with breast cancer.
@ast
The impact of an aromatase inh ...... s in women with breast cancer.
@en
type
label
The impact of an aromatase inh ...... s in women with breast cancer.
@ast
The impact of an aromatase inh ...... s in women with breast cancer.
@en
prefLabel
The impact of an aromatase inh ...... s in women with breast cancer.
@ast
The impact of an aromatase inh ...... s in women with breast cancer.
@en
P2093
P2860
P1476
The impact of an aromatase inh ...... s in women with breast cancer.
@en
P2093
B Lembersky
G J van Londen
K Vujevich
S L Greenspan
P2860
P2888
P304
P356
10.1007/S10549-010-1223-2
P407
P577
2010-11-03T00:00:00Z